Kilian Jay von Seldeneck

Kilian Jay von Seldeneck is the CFO at 4TEEN4 Pharmaceuticals, working on a breakthrough treatment in cardiogenic shock. Prior to this, von Seldeneck was a founding partner at KvS Auctions GmbH, Chief Operating Officer at biotechrabbit GmbH, and held various managerial positions at TIB Molbiol Syntheselabor GmbH, Lempertz auctioneers, Bank Sarasin & Cie AG, and UBS. Von Seldeneck also worked as a management consultant at Oliver Wyman. Von Seldeneck holds a Dr. degree from the University of St.Gallen and a lic oec degree.